Related Experiment Video
Updated: Oct 28, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
Published on: November 1, 2015
Disease course following High Disease Activity Status revealed patterns in SLE
Alberta Hoi1,2, Rachel Koelmeyer3, Julie Bonin3
1Centre for Inflammatory Diseases, School of Clinical Sciences, Monash University, Level 5, Block E, Monash Medical Centre, 246 Clayton Road, Clayton, VIC, 3168, Australia. alberta.hoi@monash.edu.
High Disease Activity Status (HDAS) in systemic lupus erythematosus (SLE) often recurs and is linked to greater damage accrual. Achieving Lupus Low Disease Activity State (LLDAS) is crucial for better patient outcomes.
Area of Science:
- Rheumatology
- Immunology
- Systemic Lupus Erythematosus Research
Background:
- High Disease Activity Status (HDAS) is a critical concern in SLE management.
- Limited data exists on the long-term outcomes of SLE patients achieving Lupus Low Disease Activity State (LLDAS).
Purpose of the Study:
- To investigate the disease course and patterns of HDAS in a real-world SLE cohort.
- To explore the association between HDAS patterns and the risk of damage accrual.
Main Methods:
- Analysis of the Monash Lupus Cohort with at least 12 months of observation.
- Definition of HDAS (SLEDAI-2K ≥ 10) and HDAS episode (time to LLDAS).
- Examination of associations between HDAS patterns (recurrent, persistent) and damage accrual.
Main Results:
- 151 of 342 SLE patients experienced HDAS, with 76.2% having recurrent HDAS.
- Recurrent or Persistent HDAS was linked to younger age at diagnosis and increased renal, serositis, or neurological manifestations.
- Longer HDAS duration (>2 years) and multiple episodes (≥4) significantly increased the likelihood of damage accrual.
Conclusions:
- HDAS episodes exhibit variable courses, with recurrent and persistent patterns increasing damage risk.
- The duration and frequency of HDAS episodes are significant predictors of long-term damage.
- Achieving LLDAS is vital for mitigating damage and improving outcomes in SLE patients.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Nephrotic Syndrome II : Assessment and Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Rheumatic Heart Disease IV: Nursing Management
Stages of Infection
Rheumatic Heart Disease I: Introduction

